{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:12Z","timestamp":1786649892341,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"\n A\n BSTRACT<\/jats:sc>\n <\/jats:title>\n \n Introduction:<\/jats:title>\n Type 1 diabetes mellitus (T1DM) management encompasses multiple, complex daily tasks that strain blood glucose monitoring and the logistics requirements for therapy, burdening the health-related quality of life (HRQoL).<\/jats:p>\n <\/jats:sec>\n \n Objective:<\/jats:title>\n This study aimed to measure and compare the QoL in an adult with T1DM with a pump user vs. multiple daily injections (MDI).<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n This case\u2013control study was conducted in a diabetes center in Riyadh, Saudi Arabia. A total of 200 adults with T1DM were managed in a 1:2 (cases\/controls) ratio. The cases referred to adults using the pump for >6 months, while controls included patients using more than two daily insulin injections. Data were collected using the self-administered diabetes quality of life (DQOL) questionnaire. Continuous and categorical variables were presented as mean \u00b1 standard deviation (SD) and percentages and underwent the\n t<\/jats:italic>\n -test and the Chi-square test, respectively.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Patients using insulin pump therapy reported notably higher satisfaction levels with diabetes management (mean score of 4.62 \u00b1 0.60 vs. 4.15 \u00b1 0.99,\n P<\/jats:italic>\n value = <0.001), general health perception (4.29 \u00b1 0.63 vs. 3.87 \u00b1 0.74,\n P<\/jats:italic>\n value = 0.001), time required for blood glucose monitoring (4.05 \u00b1 0.95 vs. 3.67 \u00b1 1.23,\n P<\/jats:italic>\n value = 0.035), and knowledge about their condition (4.59 \u00b1 0.55 vs. 4.18 \u00b1 0.93,\n P<\/jats:italic>\n value = 0.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n The overall DQOL score indicated a slightly greater health-related quality of life for the insulin pump group, but the difference was not statistically significant.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_1235_25","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:01:09Z","timestamp":1767013269000},"page":"5217-5224","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Transforming diabetes care: The effect of insulin pump technology on quality of life in adults with type 1 diabetes: An interview-based case\u2013control study"],"prefix":"10.4103","volume":"14","author":[{"given":"Ebtehal S.","family":"Almogbel","sequence":"first","affiliation":[{"name":"Department of Family and Community Medicine, College of Medicine, Qassim University, Buraidah, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"R1-20251230","doi-asserted-by":"crossref","first-page":"572192","DOI":"10.53730\/ijhs.v5n1.2864","article-title":"Health and treatment of diabetes mellitus","volume":"5","author":"Suryasa","year":"2021","journal-title":"Int J Health Sci"},{"key":"R2-20251230","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S2213-8587(22)00276-5","article-title":"Estimating the total incidence of type 1 diabetes in children and adolescents aged 0-19 years from 1990 to 2050: A global simulation-based analysis","volume":"10","author":"Ward","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R3-20251230","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/medicina59040668","article-title":"Changes in the global epidemiology of type 1 diabetes in an evolving landscape of environmental factors: Causes, challenges, and opportunities","volume":"59","author":"Ogrotis","year":"2023","journal-title":"Medicina"},{"key":"R4-20251230","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2337\/dc24-2885","article-title":"The NIDDK takes on the complications of type 1 diabetes: The diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study","volume":"48","author":"Braffett","year":"2025","journal-title":"Diabetes Care"},{"key":"R5-20251230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11154-021-09635-3","article-title":"Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives","volume":"22","author":"Boscari","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"R6-20251230","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1089\/dia.2022.0207","article-title":"Continuous subcutaneous insulin infusion in type 1 diabetes mellitus patients: Results from the Spanish National Registry","volume":"24","author":"Moreno-Fernandez","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"R7-20251230","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00592-019-01326-5","article-title":"Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: An updated meta-analysis of randomized clinical trials","volume":"56","author":"Pala","year":"2019","journal-title":"Acta Diabetol"},{"key":"R8-20251230","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2337\/dc16-2201","article-title":"Glycemic control during continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: Individual patient data meta-analysis and meta-regression of randomized controlled trials","volume":"40","author":"Pickup","year":"2017","journal-title":"Diabetes Care"},{"key":"R9-20251230","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1932296816658900","article-title":"Changes in HbA1c and weight following transition to continuous subcutaneous insulin infusion therapy in adults with type 1 diabetes","volume":"11","author":"Mehta","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"R10-20251230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/dia.2014.0139","article-title":"Predicting the effectiveness of insulin pump therapy on glycemic control in clinical practice: A retrospective study of patients with type 1 diabetes from 10 outpatient diabetes clinics in Sweden over 5 years","volume":"17","author":"Clements","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"R11-20251230","doi-asserted-by":"crossref","first-page":"109142","DOI":"10.1016\/j.jdiacomp.2025.109142","article-title":"The interplay between psychological well-being, diabetes-related distress, and glycemic control: A continuous glucose monitoring analysis from a population of adolescents with type 1 diabetes","volume":"39","author":"Bombaci","year":"2025","journal-title":"J Diabetes Complications"},{"key":"R12-20251230","first-page":"8401328","article-title":"Relation of health-related quality of life with glycemic control and use of diabetes technology in children and adolescents with type 1 diabetes: Results from a national population based study","author":"Bratke","year":"2022","journal-title":"J Diabetes Res 2022"},{"key":"R13-20251230","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/pedi.12487","article-title":"Impact of quality of life (QoL) on glycemic control (HbA1c) among adolescents and emerging adults with long-duration type 1 diabetes: A prospective cohort-study","volume":"18","author":"Stahl-Pehe","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"R14-20251230","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/pedi.12777","article-title":"Psychosocial benefits of insulin pump therapy in children with type 1 diabetes and their families: The Pumping Multicenter randomized controlled trial","volume":"19","author":"Mueller-Godeffroy","year":"2018","journal-title":"Pediatric Diabetes"},{"key":"R15-20251230","doi-asserted-by":"crossref","first-page":"1179551420959077","DOI":"10.1177\/1179551420959077","article-title":"Quality of life in children with diabetes treated with insulin pump compared with multiple daily injections in the tertiary care center","volume":"13","author":"Al Shaikh","year":"2020","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"R16-20251230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2337\/diaspect.17.1.41","article-title":"Development and validation of the diabetes quality of life brief clinical inventory","volume":"17","author":"Burroughs","year":"2004","journal-title":"Diabetes Spectrum"},{"issue":"(Suppl 2)","key":"R17-20251230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.15059","article-title":"Identifying patients with type 2 diabetes who might benefit from insulin pump therapy: Literature review, clinical opportunities, potential benefits and challenges","volume":"25","author":"Ekanayake","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"R18-20251230","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000347052","article-title":"Quality of life of children and adolescents with type 1 diabetes in Kuwait","volume":"22","author":"Abdul-Rasoul","year":"2013","journal-title":"Med Princ Pract"},{"key":"R19-20251230","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/jpc.14480","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections for type 1 diabetes","volume":"55","author":"Ross","year":"2019","journal-title":"J Paediatr Child Health"},{"key":"R20-20251230","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/dme.13841","article-title":"Pediatric quality of life inventory (Peds QL) 3.2 diabetes module for youth with type 2 diabetes: Reliability and validity","volume":"36","author":"Varni","year":"2019","journal-title":"Diabetic Med"},{"key":"R21-20251230","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s13300-024-01645-z","article-title":"Quality of life in Japanese people with type 2 diabetes switching from multiple daily insulin injections to once-daily iGlarLixi: SIMPLIFY Japan","volume":"15","author":"Ishii","year":"2024","journal-title":"Diabetes Ther"},{"issue":"(Suppl 4)","key":"R22-20251230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-543X.2006.00173.x","article-title":"The selection of children and adolescents for treatment with continuous subcutaneous insulin infusion (CSII)","volume":"7","author":"Fisher","year":"2006","journal-title":"Pediatr Diabetes"},{"key":"R23-20251230","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/pedi.12754","article-title":"Real-world outcomes of insulin pump compared to injection therapy in a population-based sample of children with type 1 diabetes","volume":"19","author":"Burckhardt","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"R24-20251230","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00592-013-0481-y","article-title":"A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes","volume":"51","author":"Mameli","year":"2014","journal-title":"Acta Diabetol"},{"key":"R25-20251230","doi-asserted-by":"crossref","first-page":"112265","DOI":"10.1016\/j.diabres.2025.112265","article-title":"Satisfaction of adult patients using continuous subcutaneous insulin infusion or multiple daily injections with type 1 diabetes mellitus","volume":"225","author":"Mach\u00e1lkov\u00e1","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"R26-20251230","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4239\/wjd.v15.i5.828","article-title":"Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges","volume":"15","author":"Emad-Eldin","year":"2024","journal-title":"World J Diabetes"},{"key":"R27-20251230","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of Type 1 diabetes management and outcomes from the T1D exchange in 2016-2018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1235_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:59:36Z","timestamp":1786647576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1235_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1235_25","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"2025-07-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}